FilingReader Intelligence
Baiyunshan Pharma announces further details on Baiyunshan Bio capital increase
June 16, 2025 at 05:14 PM UTC•By FilingReader AI
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (SSE:600332) has released a further announcement pertaining to its related transaction involving a capital increase to Baiyunshan Biopharmaceuticals. This follows their initial announcement made on May 28, 2025. The announcement includes details regarding the profit forecast related to the transaction, which was previously classified as a profit forecast under Rule 14.61 of the Listing Rules.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600332•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Guangzhou Baiyunshan Pharmaceutical Holdings publishes news
Free account required • Unsubscribe anytime